People on Medicare can get GLP-1s covered by Part D plans only if they are used for a medically accepted FDA-approved indication other than obesity, like type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea
This is because obesity is linked to worse outcomes in people with breast cancer, particularly in postmenopausal women
Su comercializacin se realiza en la categora de compuestos de investigacin cientfica
Clinical trials provide valuable perspective, but safety arises from candid discussions with a provider and transparent follow-up
Some users praise appetite control and digestion support, while others complain about slower results or pricing
They mimic the action of naturally occurring GLP-1, a hormone released by the intestine in response to food intake